SI-BONE, Inc. believes clinical research is imperative and recognizes that product safety, effectiveness and reliability are critical factors for providing excellent patient care. Our investment in clinical research sets us apart from other companies making SI-BONE the industry leader in minimally invasive SI joint fusion surgery.
Currently, SI-BONE is engaged in sponsoring three RCTs (randomized controlled trials) and one multi-center prospective study. More information on these studies can be found on ClinicalTrials.gov and are summarized in the chart below.
SI-BONE has supported numerous publications investigating a range of topics regarding the SI joint:
- Clinical outcomes and operative process measure
- Comparison of open surgery vs. MIS (minimally invasive surgery)
- Utilization of MIS SI joint fusion
- Economics of SI joint treatment
- Burden of disease